Journal archive · Complications and management · 2021
Skin Necrosis Following Rhinoplasty: A Review and Proposed Strategy on Identifying High-Risk Patients
Ferzli G, Araslanova R, Sukato D, Romo T 3rd.
What this paper says
A review of every published case of skin loss after surgical rhinoplasty found only 18 patients across eight studies, with smoking and revision surgery among the risk factors.
Overview
Loss of skin from failed blood supply after rhinoplasty is a damaging complication. This review searched Medline and Embase from database inception through September 2020 for all reported cases of skin vascular compromise after surgical rhinoplasty, excluding filler cases. The aim was to summarize the evidence and identify who is at risk.
Sections of note
- Literature review; eight studies were identified, covering 18 patients in total.
- Most patients were female, with a mean age of 30.9 years.
- Smoking was present in 23.5 percent of patients, and revision surgery was a risk factor.
- Surgical techniques associated with vascular compromise included extensive tip thinning, tight splinting and taping with a dorsal onlay graft, and combining extended alar base excision with revision open rhinoplasty.
- The most commonly affected area was the bridge, followed by the tip.
- Conservative management was used in 72.2 percent of patients, allowing the wound to heal on its own.
- The authors state the underlying studies are of low level of evidence.
- They add an expert opinion on assessing nasal skin before surgery to identify patients in whom rhinoplasty might be avoided.
What it means for a patient
- Only 18 published cases exist worldwide, which indicates the complication is rare but also that reporting is incomplete.
- Smoking, previous nasal surgery and certain aggressive techniques were the recurring features.
- Most cases were managed without further surgery, letting the wound heal by itself.
- Because this pools case reports rather than a defined population, it cannot give a rate.
Why this paper matters
Skin loss on the nose is difficult to repair and disfiguring, and surgeons have had almost no consolidated evidence on who is at risk. This review assembles what exists. Whether the identified factors predict risk in any prospective way is untested.
Terms
- Skin necrosis: death of skin from loss of blood supply.
- Vascular compromise: reduced blood flow to tissue.
- Conservative management: treating without further surgery.
- Healing by secondary intention: allowing a wound to close on its own rather than stitching it.
- Alar base excision: removing tissue at the base of the nostril to narrow it.
Summary written by rhinoplasty.cc from the abstract, 2026-09-09; not medical advice. The authors' own abstract follows.
From the abstract
“Vascular compromise leading to cutaneous loss following surgical rhinoplasty is a devastating complication. The objective of this review is to identify all reported cases in literature published in English and summarize the current evidence to identify the patients at risk of this complication following surgery. A…”
Excerpt; the full abstract is on PubMed.
Citation
Start here
What the rhinoplasty literature says on this paper's topic, cited line by line to PubMed.
Related papers
Same topic, 2021.
- ASJ Corrigendum to: The Effect of Autologous Fat Grafting on Edema and Ecchymoses in Primary Open RhinoplastyGabrick K, Walker M, Timberlake A et al.2021PMID 31605604
- APS Bilateral Tip Add-On Grafts: Concept, Applications and Complications in East Asian RhinoplastyWu L, Wang H, Xu Y et al.2021PMID 34085104Summary
- FPS Indications for Preservation Rhinoplasty: Avoiding ComplicationsFerraz MBJ, Sella GCP2021PMID 33715148Summary
- FPSAM Evaluation of Postoperative Infection Rates in 3084 Rhinoplasty Cases Using Antibiotic Soaks and/or IrrigationsToriumi DM, Kowalczyk DM, Cristel RT et al.2021PMID 33798400Summary
- PRS Prospective Randomized Trial Comparing Opioids versus Nonsteroidal Antiinflammatory Drugs for Postoperative Analgesia in Outpatient RhinoplastyFrants A, Garber D, Lafer MP et al.2021PMID 33370050Summary